Related Experiment Videos
Three new exon 10 glucose-6-phosphate dehydrogenase mutations
E Beutler1, B Westwood, A Melemed
1Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.
Blood Cells, Molecules & Diseases
|January 1, 1995
Summary
Three new glucose-6-phosphate dehydrogenase (G6PD) gene mutations causing hereditary non-spherocytic hemolytic anemia (HNSHA) were identified. These mutations, located in exon 10, contribute to the growing list of G6PD gene variants.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Hereditary non-spherocytic hemolytic anemia (HNSHA) is a group of inherited disorders characterized by red blood cell destruction.
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common genetic disorder that can lead to hemolytic anemia.
- Understanding G6PD gene mutations is crucial for diagnosing and managing HNSHA.
Observation:
- Three novel mutations in the G6PD gene were identified in patients with HNSHA.
- These mutations, named G6PD Calvo Mackenna, G6PD Riley, and G6PD Wisconsin, involve specific nucleotide transitions and transversions.
- All identified mutations are located within exon 10 of the G6PD gene, a region known to harbor HNSHA-associated mutations.
Findings:
- G6PD Calvo Mackenna results from an A-to-G transition at cDNA nucleotide 1138, substituting valine for isoleucine at amino acid 380.
- G6PD Riley arises from a T-to-C transition at cDNA nucleotide 1139, changing isoleucine to threonine at amino acid 380.
- G6PD Wisconsin is caused by a C-to-G transversion at cDNA nucleotide 1177, replacing arginine with glycine at amino acid 393.
Implications:
- The identification of these new mutations expands the known spectrum of G6PD gene defects associated with HNSHA.
- The clustering of mutations in exon 10 suggests this region is critical for G6PD enzyme function.
- This research contributes to a comprehensive catalog of G6PD mutations, aiding in genetic counseling and diagnostic efforts.